| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 04/16/2003 | CN1410121A Medicine for treating archosyrinx and its preparation method |
| 04/16/2003 | CN1410106A Xiatare ointment and its preparation method |
| 04/16/2003 | CN1410098A Chinese patent medicine for treating cancer |
| 04/16/2003 | CN1410097A Chinese patent medicine for treating mastoncus |
| 04/16/2003 | CN1410094A Ointment for treating nuchal rigidity |
| 04/16/2003 | CN1410082A Bone strengthening pill and its preparation method |
| 04/16/2003 | CN1105576C Insulin analog formulation |
| 04/16/2003 | CN1105567C Medicine for treating leukemia and its preparing process |
| 04/16/2003 | CN1105561C Medicine for treating underarm odour and beriberi |
| 04/16/2003 | CA2407771A1 Mixtures for stimulating glucose up-take |
| 04/15/2003 | US6548687 Chromium L-threonate, process for preparation of the same and their use |
| 04/15/2003 | US6548551 Administration of Citalopram and Phentermine to facilitate weight loss for patient |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6547811 Method for inducing hypothermia |
| 04/10/2003 | WO2003028767A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods |
| 04/10/2003 | WO2003028766A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 04/10/2003 | WO2003028747A1 Ingestible nerve and circulatory nutritional formulation |
| 04/10/2003 | WO2003028742A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 04/10/2003 | WO2003028741A1 Composition of hypochlorous acid and its applications |
| 04/10/2003 | WO2003028740A1 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminium fluoride |
| 04/10/2003 | WO2003028699A1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 04/10/2003 | WO2003028697A2 Liposome loading with metal ions |
| 04/10/2003 | WO2003028696A2 Compositions for delivery of drug combinations |
| 04/10/2003 | WO2003028623A2 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes |
| 04/10/2003 | WO2003028590A1 Rational drug therapy device and methods |
| 04/10/2003 | WO2003013563A3 Mineral-protein preparations (mpp) and neuropathies in diabetes |
| 04/10/2003 | WO2003000114A3 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/10/2003 | WO2002102394A3 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/10/2003 | WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 04/10/2003 | WO2002036135A3 Compositions for antitumour treatment containing ecteinascidin 743 |
| 04/10/2003 | US20030069202 Compositions, kits, and methods for promoting defined health benefits |
| 04/10/2003 | US20030068391 Combination of an antioxidant, an antiinflammatory agent, circulatory enhancement agent, vasodilator, nerve growth regeneration agent, gycemic conrol agent, sorbitol inhibitor, lipid reduction agent, pancreatic stem cell support agent |
| 04/10/2003 | US20030068386 Method of treating cancerous disease |
| 04/10/2003 | US20030068372 Nutritional composition |
| 04/10/2003 | US20030068368 Solid dosage form; superior disintegration, dissolution and compression characteristics |
| 04/10/2003 | US20030068359 Poultry and livestock feed additive |
| 04/10/2003 | US20030068351 >/= 1% zinc oxide, a fungicide, a batericide, >/= 5% water-absorbing macromolecular material dispersed in a water immiscible vehicle; treating skin that is exposed to excessive amounts of moisture |
| 04/10/2003 | US20030066753 Stable taurolidine electrolyte solutions |
| 04/10/2003 | CA2722319A1 Water-in-oil emulsions with ethylene oxide groups, compostions, and methods |
| 04/10/2003 | CA2461553A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 04/09/2003 | EP1300424A1 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1299313A1 Process for the debromination of an aqueous salt solution using ozone |
| 04/09/2003 | EP1299121A2 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity |
| 04/09/2003 | EP1299112A2 Compositions for treating eye discomfort, containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 04/09/2003 | EP1299105A2 Compositions comprising folic acid and zinc for improving male fertility |
| 04/09/2003 | EP1299068A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 04/09/2003 | EP1299011A2 Composition for the treatment of migraine |
| 04/09/2003 | EP1094824A4 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 04/09/2003 | EP0951288B1 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia |
| 04/09/2003 | EP0862440B1 Therapeutic use of hemoglobin in promoting wound healing |
| 04/09/2003 | CN1408414A External use medicine for curing piles |
| 04/09/2003 | CN1408413A Pellet capable of curing infantile anorexia and convulsion |
| 04/09/2003 | CN1408411A Bear gall Korean ginseng pill for regulating blood pressure and its preparing method |
| 04/09/2003 | CN1408409A Hair restorer |
| 04/09/2003 | CN1408370A Novel compound preparation of oyster calcium (including calcium carbonate) and iron compensation agent |
| 04/09/2003 | CN1408365A Local applied medicine composition for curing subcutaneous tumor |
| 04/09/2003 | CN1408364A Recipe composition of iron-compensation agent dry suspension |
| 04/09/2003 | CN1408352A Formula of iron-compensating agent chewing tablet |
| 04/09/2003 | CN1104901C Medicinal preparation containing lipophilicity inert gas |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | US6545010 Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
| 04/08/2003 | US6544979 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 04/08/2003 | US6544621 Floor covering articles comprising antimicrobial adhesive latex components |
| 04/08/2003 | US6544561 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 04/08/2003 | US6544547 Nutritional composition containing methionine |
| 04/08/2003 | US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 04/08/2003 | US6544539 Composition and method for producing lubricating, germicide foam |
| 04/08/2003 | CA2061601C Methods and compositions for the treatment of infection and control of flora |
| 04/08/2003 | CA2023810C Pharmaceutical composition |
| 04/07/2003 | WO2002038152A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus |
| 04/07/2003 | CA2425192A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus |
| 04/03/2003 | WO2003026717A1 Nitric oxide-releasing coated medical devices and method of preparing same |
| 04/03/2003 | WO2003026714A1 Porous ceramic composite bone grafts |
| 04/03/2003 | WO2003026681A1 Inactivation of papillomavirus |
| 04/03/2003 | WO2003026680A2 Method and topical formulation for treating skin conditions associated with aging |
| 04/03/2003 | WO2003026679A2 Saline solutions for clinical or cosmetic use |
| 04/03/2003 | WO2003026678A1 Novel pharmaceutical composition with improved defoaming activity |
| 04/03/2003 | WO2003026644A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 04/03/2003 | WO2003026601A1 Oral composition for treating sensitive teeth |
| 04/03/2003 | WO2003026581A2 Pharmaceutical compositions and methods for treating cancer |
| 04/03/2003 | WO2003026574A2 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 04/03/2003 | WO2003026570A2 Reduced toxicity cisplatin formulations and methods for using the same |
| 04/03/2003 | WO2003026444A1 Mixture of base-containing micronutrient substances |
| 04/03/2003 | WO2003015696A8 Ultra fine dead sea mineral compound and method of manufacture |
| 04/03/2003 | WO2002100418B1 Exothermic formulations for the treatment of ectoparasites |
| 04/03/2003 | WO2002049694A3 Sterile bicarbonate-free dialysis concentrate solutions |
| 04/03/2003 | WO2002017852A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 04/03/2003 | US20030065026 Synergistic mixture with metal compound |
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/03/2003 | US20030064949 Anticancer agents |
| 04/03/2003 | US20030064522 Diagnosisng ischemia in humans; obtain sample, detect and measure concentration of ischemic marker, compare to control, evaluate for ischemic injury |
| 04/03/2003 | US20030064514 Oligonucleotide for use as antiproliferative agent |
| 04/03/2003 | US20030064115 Applying voltage across cathode and anode to generate nitric oxide; contacting transport gas with solution of nitric dioxide oxide precursor to form a therapeutic gas; transporting therapeutic gas to mammal |
| 04/03/2003 | US20030064114 For vasodilatation and inhibition of transplant rejection |
| 04/03/2003 | US20030064113 For treating wood and other cellulose products to improve the flame retardancy, and insecticidal and fungicidal properties of the products |
| 04/03/2003 | US20030064104 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 04/03/2003 | US20030064028 Drug delivery; for inhalation therapy for pulmonary hypertension |